Children know best whether an allergy spray works for them

A recent 14-day study that compared the efficacy of an allergy spray in 304 children aged 6-11 years with seasonal allergic rhinitis showed that the result depended on who assessed symptoms: children themselves or their caregiver.

Children reported significant improvement in their symptoms when they received MP-AzeFlu (Dymista) compared with placebo. Caregivers, on the other hand, where unable to accurately gauge the severity of on their 's behalf.

"Symptom severity assessment by caregivers and children cannot be assumed to be the same. In fact, caregivers are less sensitive than children in assessing response to treatment, at least with available tools," said Dr. William Berger, lead author of the Pediatric Allergy and Immunology study. "In this regard children, and not , appear to know best!"

Explore further

Peanuts don't panic parents as much as milk and eggs

More information: William Berger et al. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment, Pediatric Allergy and Immunology (2016). DOI: 10.1111/pai.12540
Provided by Wiley
Citation: Children know best whether an allergy spray works for them (2016, March 7) retrieved 23 September 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more